/tags/pfizer Pfizer en-US Copyright Mon, 22 Aug 2022 16:45:01 GMT /npr-news/npr-news/2022-08-22/pfizer-asks-fda-to-greenlight-new-omicron-booster-shots-which-could-arrive-this-fall Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September. Mon, 22 Aug 2022 16:45:01 GMT /npr-news/npr-news/2022-08-22/pfizer-asks-fda-to-greenlight-new-omicron-booster-shots-which-could-arrive-this-fall Pien Huang, Will Stone /coronavirus/2022-05-18/ohio-department-of-health-gives-covid-19-update-amid-rise-in-cases Despite the nation reaching the grim milestone of 1 million COVID deaths, ODH Director Dr. Bruce Vanderhoff says Ohio is doing "well" compared to previous spikes. Wed, 18 May 2022 17:58:40 GMT /coronavirus/2022-05-18/ohio-department-of-health-gives-covid-19-update-amid-rise-in-cases Matthew Rand /coronavirus/npr-news/2022-05-17/fda-authorizes-first-covid-booster-for-children-ages-5-to-11 The Food and Drug Administration expanded authorization of Pfizer-BioNTech's COVID vaccine to enable kids ages 5 to 11 who were vaccinated at least five months ago to get a third shot. Tue, 17 May 2022 14:45:00 GMT /coronavirus/npr-news/2022-05-17/fda-authorizes-first-covid-booster-for-children-ages-5-to-11 Rob Stein /npr-news/2022-03-22/pfizer-launches-a-recall-of-blood-pressure-drugs-due-to-a-potential-carcinogen The company warned consumers of several tainted lots of Accuretic and two other versions of the drug because of the presence of a nitrosamine above the acceptable daily intake level. Tue, 22 Mar 2022 20:08:45 GMT /npr-news/2022-03-22/pfizer-launches-a-recall-of-blood-pressure-drugs-due-to-a-potential-carcinogen Vanessa Romo /coronavirus/2022-03-18/a-fourth-vaccine-could-be While approval would only be for those populations, an infectious disease specialist from Mount Carmel Medical Group says may be good for everyone. Fri, 18 Mar 2022 20:17:44 GMT /coronavirus/2022-03-18/a-fourth-vaccine-could-be Tyler Thompson /npr-news/2022-03-15/pfizer-biontech-will-seek-authorization-for-second-covid-booster-for-older-adults Pfizer and BioNTech are planning to ask the Food and Drug Administration to authorize a second COVID-19 booster shot for people age 65 and older. Tue, 15 Mar 2022 18:51:04 GMT /npr-news/2022-03-15/pfizer-biontech-will-seek-authorization-for-second-covid-booster-for-older-adults Scott Hensley /npr-news/2022-02-28/pfizer-vaccines-protection-against-covid-wanes-quickly-in-kids-ages-5-11-study-says New research out of New York found the protection of the vaccine against infection in kids ages 5 to 11 dropped from 68% to 12%. Tue, 01 Mar 2022 01:01:35 GMT /npr-news/2022-02-28/pfizer-vaccines-protection-against-covid-wanes-quickly-in-kids-ages-5-11-study-says Vanessa Romo, Rob Stein /coronavirus/2022-01-06/cdc-recommends-pfizer-covid-booster-for-kids-as-young-as-12 The new recommendation for adolescents age 12-17 came hours after a panel of CDC advisers voted in favor of it. The boosters should be given five months after initial immunization. Thu, 06 Jan 2022 12:51:37 GMT /coronavirus/2022-01-06/cdc-recommends-pfizer-covid-booster-for-kids-as-young-as-12 Jonathan Franklin /2022-01-04/the-cdc-now-recommends-pfizer-boosters-after-5-months-down-from-6 The move to shorten the Pfizer booster interval comes as the U.S. shatters daily case records. The recommended interval for those who received Moderna or Johnson & Johnson vaccines has not changed. Tue, 04 Jan 2022 18:08:39 GMT /2022-01-04/the-cdc-now-recommends-pfizer-boosters-after-5-months-down-from-6 Becky Sullivan /2022-01-03/the-fda-authorizes-a-pfizer-booster-shot-for-children-ages-12-to-15 The authorization comes in the midst of an explosion of COVID-19 cases nationwide driven by the omicron variant — a surge that has brought a spike in pediatric hospitalizations. Mon, 03 Jan 2022 17:11:22 GMT /2022-01-03/the-fda-authorizes-a-pfizer-booster-shot-for-children-ages-12-to-15 Scott Hensley, Joe Hernandez